The 123m they are raising is the 15% they can issue without going to shareholders.They will seek shareholder approval for the balance.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025